Halozyme Therapeutics Inc
Officers & Directors
1. Dr. Helen Torley: Chief Executive Officer and Director
Dr. Helen Torley is a biopharmaceutical executive with over 25 years of experience in the industry. She joined Halozyme in 2014 as President and Chief Executive Officer. Prior to her role at Halozyme, Dr. Torley served as Senior Vice President of Commercial at Onyx Pharmaceuticals and held various executive positions at Amgen Inc.
2. Elaine D. Sun: Chief Financial Officer and Senior Vice President, Corporate Development
Elaine Sun has been with Halozyme since 2009 and has held several finance and corporate development roles within the company. Prior to joining Halozyme, she was a healthcare investment banker at Merrill Lynch.
3. Dr. Mark J. Gergen: Chief Operating Officer
Dr. Mark Gergen joined Halozyme in 2018 as Chief Operating Officer. Prior to his role at Halozyme, he was a Senior Vice President at Merck & Co. Inc. and held various executive positions at Pfizer Inc.
4. Dr. Mahmoud Ghazzi: Chief Medical Officer
Dr. Mahmoud Ghazzi joined Halozyme in 2017 as Chief Medical Officer. Prior to his role at Halozyme, he held various executive positions at Astellas Pharma Inc. and Roche Pharmaceuticals.
5. Dr. Alison Armour: Executive Vice President, Technical Operations
Dr. Alison Armour has been with Halozyme since 2012 and has held several positions within the company's technical operations team. Prior to joining Halozyme, she held various positions at Amgen and Pfizer.
Directors:
1. Dr. Helen Torley: Chief Executive Officer and Director
2. Kenneth J. Kelley: Chairman of the Board of Directors
3. William J. Rieflin: Director
4. Spiros Jamas: Director
5. Harry Hixson Jr.: Director
6. Kathleen A
Halozyme Therapeutics Inc currently has 423 employees.
|
